Durable remission after rechallenge with ipilimumab and nivolumab in metastatic Merkel cell carcinoma refractory to avelumab: Any role for sequential immunotherapy?

被引：12

作者：

Khaddour, Karam ^{[1
]}

Rosman, Ilana S. ^{[2
,3
]}

Dehdashti, Farrokh ^{[4
]}

Ansstas, George ^{[1
]}

机构：

[1] Washington Univ, Dept Med, Div Med Oncol, St Louis, MO 63130 USA

[2] Washington Univ, Div Dermatol, St Louis, MO USA

[3] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA

[4] Washington Univ, Dept Radiol, Div Nucl Med, St Louis, MO USA

来源：

JOURNAL OF DERMATOLOGY | 2021年 / 48卷 / 02期

关键词：

D O I：

10.1111/1346-8138.15621

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E80 / E81

页数：2

共 5 条

[1] Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer [J].

Bhatia, Shailender ;

Afanasiev, Olga ;

Nghiem, Paul .

CURRENT ONCOLOGY REPORTS, 2011, 13 (06) :488-497

[2] Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma? [J].

Glutsch, V. ;

Kneitz, H. ;

Goebeler, M. ;

Gesierich, A. ;

Schilling, B. .

ANNALS OF ONCOLOGY, 2019, 30 (10) :1667-1668

[3] Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Haanen, J. B. A. G. ;

Carbonnel, F. ;

Robert, C. ;

Kerr, K. M. ;

Peters, S. ;

Larkin, J. ;

Jordan, K. .

ANNALS OF ONCOLOGY, 2017, 28 :119-142

[4] Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥ 1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial [J].

Kaufman, Howard L. ;

Russell, Jeffery S. ;

Hamid, Omid ;

Bhatia, Shailender ;

Terheyden, Patrick ;

D'Angelo, Sandra P. ;

Shih, Kent C. ;

Lebbe, Celeste ;

Milella, Michele ;

Brownell, Isaac ;

Lewis, Karl D. ;

Lorch, Jochen H. ;

von Heydebreck, Anja ;

Hennessy, Meliessa ;

Nghiem, Paul .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6

[5] Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy [J].

Miller, Natalie J. ;

Church, Candice D. ;

Fling, Steven P. ;

Kulikauskas, Rima ;

Ramchurren, Nirasha ;

Shinohara, Michi M. ;

Kluger, Harriet M. ;

Bhatia, Shailender ;

Lundgren, Lisa ;

Cheever, Martin A. ;

Topalian, Suzanne L. ;

Nghiem, Paul .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6

← 1 →